Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 84

Cited In for PubMed (Select 20551973)

1.

A Small Antigenic Determinant of the Chikungunya Virus E2 Protein Is Sufficient to Induce Neutralizing Antibodies which Are Partially Protective in Mice.

Weber C, Büchner SM, Schnierle BS.

PLoS Negl Trop Dis. 2015 Apr 23;9(4):e0003684. doi: 10.1371/journal.pntd.0003684. eCollection 2015 Apr.

2.

Proteomics profiling of chikungunya-infected Aedes albopictus C6/36 cells reveal important mosquito cell factors in virus replication.

Lee RC, Chu JJ.

PLoS Negl Trop Dis. 2015 Mar 4;9(3):e0003544. doi: 10.1371/journal.pntd.0003544. eCollection 2015 Mar.

3.

Role of pentraxin 3 in shaping arthritogenic alphaviral disease: from enhanced viral replication to immunomodulation.

Foo SS, Chen W, Taylor A, Sheng KC, Yu X, Teng TS, Reading PC, Blanchard H, Garlanda C, Mantovani A, Ng LF, Herrero LJ, Mahalingam S.

PLoS Pathog. 2015 Feb 19;11(2):e1004649. doi: 10.1371/journal.ppat.1004649. eCollection 2015 Feb.

4.

Residue-level resolution of alphavirus envelope protein interactions in pH-dependent fusion.

Zeng X, Mukhopadhyay S, Brooks CL 3rd.

Proc Natl Acad Sci U S A. 2015 Feb 17;112(7):2034-9. doi: 10.1073/pnas.1414190112. Epub 2015 Feb 2.

PMID:
25646410
5.

Chikungunya virus mutation, Indonesia, 2011.

Maha MS, Susilarini NK, Hariastuti NI; Subangkit.

Emerg Infect Dis. 2015 Feb;21(2):379-81. doi: 10.3201/eid2102.141121. No abstract available.

6.

CD8+ T cells control Ross River virus infection in musculoskeletal tissues of infected mice.

Burrack KS, Montgomery SA, Homann D, Morrison TE.

J Immunol. 2015 Jan 15;194(2):678-89. doi: 10.4049/jimmunol.1401833. Epub 2014 Dec 8.

PMID:
25488988
7.

pH-Dependent entry of chikungunya virus fusion into mosquito cells.

Nuckols JT, McAuley AJ, Huang YJ, Horne KM, Higgs S, Davey RA, Vanlandingham DL.

Virol J. 2014 Dec 5;11(1):215. doi: 10.1186/s12985-014-0215-y.

8.

Multiple immune factors are involved in controlling acute and chronic chikungunya virus infection.

Poo YS, Rudd PA, Gardner J, Wilson JA, Larcher T, Colle MA, Le TT, Nakaya HI, Warrilow D, Allcock R, Bielefeldt-Ohmann H, Schroder WA, Khromykh AA, Lopez JA, Suhrbier A.

PLoS Negl Trop Dis. 2014 Dec 4;8(12):e3354. doi: 10.1371/journal.pntd.0003354. eCollection 2014 Dec.

9.

Dengue and Chikungunya fever among viral diseases in outpatient febrile children in Kilosa district hospital, Tanzania.

Chipwaza B, Mugasa JP, Selemani M, Amuri M, Mosha F, Ngatunga SD, Gwakisa PS.

PLoS Negl Trop Dis. 2014 Nov 20;8(11):e3335. doi: 10.1371/journal.pntd.0003335. eCollection 2014 Nov.

10.

Osteoblasts from osteoarthritis patients show enhanced susceptibility to Ross River virus infection associated with delayed type I interferon responses.

Chen W, Foo SS, Li RW, Smith PN, Mahalingam S.

Virol J. 2014 Nov 19;11(1):189. doi: 10.1186/s12985-014-0189-9.

11.

Neutralization activity of patient sera collected during the 2008-2009 Chikungunya outbreak in Thailand.

Kishishita N, Sasayama M, Takeda N, Sa-Ngasang A, Anuegoonpipat A, Anantapreecha S.

J Clin Microbiol. 2015 Jan;53(1):184-90. doi: 10.1128/JCM.02744-14. Epub 2014 Nov 5.

PMID:
25378567
12.

Exposure of epitope residues on the outer face of the chikungunya virus envelope trimer determines antibody neutralizing efficacy.

Fong RH, Banik SS, Mattia K, Barnes T, Tucker D, Liss N, Lu K, Selvarajah S, Srinivasan S, Mabila M, Miller A, Muench MO, Michault A, Rucker JB, Paes C, Simmons G, Kahle KM, Doranz BJ.

J Virol. 2014 Dec;88(24):14364-79. doi: 10.1128/JVI.01943-14. Epub 2014 Oct 1.

PMID:
25275138
13.

Development and application of a reversed-phase high-performance liquid chromatographic method for quantitation and characterization of a Chikungunya virus-like particle vaccine.

Shytuhina A, Pristatsky P, He J, Casimiro DR, Schwartz RM, Hoang VM, Ha S.

J Chromatogr A. 2014 Oct 17;1364:192-7. doi: 10.1016/j.chroma.2014.05.087. Epub 2014 Jun 19.

PMID:
25234500
14.

Prime-boost immunization strategies against Chikungunya virus.

Hallengärd D, Lum FM, Kümmerer BM, Lulla A, Lulla V, García-Arriaza J, Fazakerley JK, Roques P, Le Grand R, Merits A, Ng LF, Esteban M, Liljeström P.

J Virol. 2014 Nov;88(22):13333-43. doi: 10.1128/JVI.01926-14. Epub 2014 Sep 10.

15.

Chikungunya virus exploits miR-146a to regulate NF-κB pathway in human synovial fibroblasts.

Selvamani SP, Mishra R, Singh SK.

PLoS One. 2014 Aug 1;9(8):e103624. doi: 10.1371/journal.pone.0103624. eCollection 2014.

16.

An integrated lab-on-chip for rapid identification and simultaneous differentiation of tropical pathogens.

Tan JJ, Capozzoli M, Sato M, Watthanaworawit W, Ling CL, Mauduit M, Malleret B, Grüner AC, Tan R, Nosten FH, Snounou G, Rénia L, Ng LF.

PLoS Negl Trop Dis. 2014 Jul 31;8(7):e3043. doi: 10.1371/journal.pntd.0003043. eCollection 2014.

17.

Detection of east/central/south African genotype of chikungunya virus in Myanmar, 2010.

Tun MM, Thant KZ, Inoue S, Nabeshima T, Aoki K, Kyaw AK, Myint T, Tar T, Maung KT, Hayasaka D, Morita K.

Emerg Infect Dis. 2014 Aug;20(8):1378-81. doi: 10.3201/eid2008.131431.

18.

Preparedness for threat of chikungunya in the pacific.

Roth A, Hoy D, Horwood PF, Ropa B, Hancock T, Guillaumot L, Rickart K, Frison P, Pavlin B, Souares Y.

Emerg Infect Dis. 2014 Aug;20(8). doi: 10.3201/eid2008.130696.

19.

Vector competence of Aedes aegypti and Aedes vittatus (Diptera: Culicidae) from Senegal and Cape Verde archipelago for West African lineages of chikungunya virus.

Diagne CT, Faye O, Guerbois M, Knight R, Diallo D, Faye O, Ba Y, Dia I, Faye O, Weaver SC, Sall AA, Diallo M.

Am J Trop Med Hyg. 2014 Sep;91(3):635-41. doi: 10.4269/ajtmh.13-0627. Epub 2014 Jul 7.

PMID:
25002293
20.

Comparing dengue and chikungunya emergence and endemic transmission in A. aegypti and A. albopictus.

Manore CA, Hickmann KS, Xu S, Wearing HJ, Hyman JM.

J Theor Biol. 2014 Sep 7;356:174-91. doi: 10.1016/j.jtbi.2014.04.033. Epub 2014 May 4.

PMID:
24801860
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk